Skip to main content
Terug
Watch Compare

VYCOR MEDICAL INC

Datakwaliteit: 100%
VYCO
OTC Manufacturing Measuring & Analyzing Instruments
€ 0,08
▼ € 0,02 (-17,53%)
Marktkapitalisatie: 3,24 M
Prijs
€ 0,10
Marktkapitalisatie
3,24 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 7,54% annually over 5 years — modest growth
Negative free cash flow of -18.695,0
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9,70%
Capital efficient — spends only 0,28% of revenue on capex

Groei

Revenue Growth (5Y)
7,54%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)17,24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-3,89%
Op. Margin1,82%

Veiligheid

Debt / Equity
N/A
Current Ratio0,14
Interest Coverage2,57

Waardering

PE (TTM)
-44,70
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDA33,96
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -44,7 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -3,9 -41,5
Rev Growth 5Y % 7,5 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 17,24% Revenue Growth (3Y) 12,95%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 7,54% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,86 M Net Income (TTM) -72.426,0
ROE N/A ROA -7,96%
Gross Margin 83,78% Operating Margin 1,82%
Net Margin -3,89% Free Cash Flow (TTM) -18.695,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,14
Interest Coverage 2,57 Asset Turnover 2,05
Working Capital -4,15 M Tangible Book Value -4,02 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -44,70 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1,74
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 33,96 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,58%
Market Cap 3,24 M Enterprise Value 3,17 M
Per Share
EPS (Diluted TTM) -0,01 Revenue / Share 0,06
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,28% FCF Conversion 25,81%
SBC-Adj. FCF -73.638 Growth Momentum 9,70

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,86 M 1,59 M 1,46 M 1,22 M 1,39 M
Net Income -72.426,0 -107.200,0 -69.691,0 -404.917,0 -435.662,0
EPS (Diluted) -0,01 -0,01 -0,01 — —
Gross Profit 1,56 M 1,42 M 1,32 M 1,08 M 1,26 M
Operating Income 33.900,0 -9.145,0 40.191,0 -306.514,0 -435.954,0
EBITDA — — — — —
R&D Expenses 9.963,0 15.325,0 22.558,0 15.159,0 15.159,0
SG&A Expenses 1,46 M 1,36 M 1,20 M 1,33 M 1,61 M
D&A 59.521,0 59.521,0 57.497,0 58.232,0 66.070,0
Interest Expense 13.200,0 13.200,0 13.200,0 13.200,0 13.200,0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 830.420,0 998.117,0 992.298,0 860.178,0 935.364,0
Total Liabilities 4,92 M 4,69 M 4,32 M 3,80 M 3,33 M
Shareholders' Equity -4,09 M -3,69 M -3,33 M -2,94 M -2,40 M
Total Debt — — — — 150.000,0
Cash & Equivalents 86.982,0 105.648,0 57.291,0 37.035,0 90.941,0
Current Assets 563.422,0 695.719,0 584.090,0 517.763,0 487.411,0
Current Liabilities 4,78 M 4,50 M 4,07 M 3,65 M 3,15 M